China vs India
China vs India: which way does the decade lean?
Wellow turned a belief about India structurally outperforming China through this decade into a structured thesis. Below: the supply-chain shift, the ranked exposure across both markets, and the risks that would invalidate the call.
The thesis backing this page is being refreshed. Try generating one yourself with the topic on your mind.
Frequently asked
- Why does India structurally outperform China this decade?
- Demographics, manufacturing reshoring under the China-plus-one strategy, and a reform-friendly capital-markets posture. Indian listed equities have been compounding earnings faster than Chinese listed equities since the mid-2020s, and the gap looks structural, not cyclical.
- How do I get exposure to India without picking single names?
- Broad-market India ETFs are the cleanest unscreened exposure. The thesis below ranks the specific tickers we'd lead with for thesis purity, including the ETFs that capture the demographic and manufacturing tailwinds without single-name idiosyncratic risk.
- Is China still investable as a relative-value play?
- Yes for traders willing to underwrite policy risk. The valuation gap to India and to global peers is wide enough that any meaningful pivot in capital-markets policy or property-sector resolution could close part of the gap fast. The thesis below names the specific surfaces to play that.
- What would invalidate the India-over-China thesis?
- A faster-than-expected resolution of China's property overhang, a successful capital-markets reopening for foreign flows, or an Indian political shift that disrupts the reform agenda. The thesis below names the specific data points to watch.